Literature DB >> 9568461

The effects of IGF-I and IGF-II on proliferation and differentiation of human osteoblasts and interactions with growth hormone.

B L Langdahl1, M Kassem, M K Møller, E F Eriksen.   

Abstract

BACKGROUND: We have previously shown that growth hormone (GH) consistently stimulates proliferation of human osteoblasts in vitro. In rat osteoblasts, GH augments the effects of insulin-like growth factor (IGF) I on cell proliferation and differentiation. We therefore investigated the effects of IGF-I and -II alone and in combination with GH on human osteoblasts in vitro.
METHODS: Human osteoblast-like cells (HOB) were established from trabecular explants (n = 18) and human marrow stromal cells (HMS) from marrow aspiration (n = 21). The cell cultures were stimulated with IGF-I or IGF-II (1, 10 or 100 ng mL-1) alone, in combination with hGH (100 ng mL-1) or after prestimulation with hGH.
RESULTS: IGF-I alone, in combination with hGH and after pretreatment with hGH, increased proliferation of HOB and HMS by 49-190% (P < 0.05-0.01). IGF-II alone, in combination with hGH and after pretreatment with hGH increased proliferation of HOB by 57-158% (P < 0.01). In HMS only IGF-II in combination with hGH and after prestimulation with hGH increased proliferation. IGF-I alone and in combination with hGH decreased alkaline phosphatase (AP) in both cell types. IGF-II did not affect AP in HOB, but increased AP in HMS, this effect was abolished by hGH. In HOB, collagen production (PICP) was increased by IGF-II but unaffected by IGF-I. In HMS, PICP was decreased by IGF-I and -II but increased by hGH. Co-stimulation further increased PICP.
CONCLUSION: IGF-I and -II exerted proliferative effects on both HOB and HMS. Co-stimulation with GH exhibited synergism in enhancing the proliferative response. In HMS prestimulation improved the proliferative response significantly. The effects of the IGFs on differentiation are more complex and dependent on cell maturation and of the IGF used.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9568461     DOI: 10.1046/j.1365-2362.1998.00265.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  18 in total

1.  Osteoblast-restricted Disruption of the Growth Hormone Receptor in Mice Results in Sexually Dimorphic Skeletal Phenotypes.

Authors:  Vandana Singhal; Brian C Goh; Mary L Bouxsein; Marie-Claude Faugere; Douglas J DiGirolamo
Journal:  Bone Res       Date:  2013-03-29       Impact factor: 13.567

Review 2.  The role of the insulin‑like growth factor (IGF) axis in osteogenic and odontogenic differentiation.

Authors:  H Al-Kharobi; R El-Gendy; D A Devine; J Beattie
Journal:  Cell Mol Life Sci       Date:  2014-04       Impact factor: 9.261

3.  Increased In Vitro Osteopotential in SHED Associated with Higher IGF2 Expression When Compared with hASCs.

Authors:  Roberto Dalto Fanganiello; Felipe Augusto Andre Ishiy; Gerson Shigeru Kobayashi; Lucas Alvizi; Daniele Yumi Sunaga; Maria Rita Passos-Bueno
Journal:  Stem Cell Rev Rep       Date:  2015-08       Impact factor: 5.739

Review 4.  Controversies surrounding high-protein diet intake: satiating effect and kidney and bone health.

Authors:  Marta Cuenca-Sánchez; Diana Navas-Carrillo; Esteban Orenes-Piñero
Journal:  Adv Nutr       Date:  2015-05-15       Impact factor: 8.701

5.  Protein intake and risk of hip fractures in postmenopausal women and men age 50 and older.

Authors:  T T Fung; H E Meyer; W C Willett; D Feskanich
Journal:  Osteoporos Int       Date:  2017-01-10       Impact factor: 4.507

Review 6.  Vertebral cross-sectional area: an orphan phenotype with potential implications for female spinal health.

Authors:  T A L Wren; S Ponrartana; V Gilsanz
Journal:  Osteoporos Int       Date:  2016-12-14       Impact factor: 4.507

Review 7.  Bone metabolism in anorexia nervosa: molecular pathways and current treatment modalities.

Authors:  D J Howgate; S M Graham; A Leonidou; N Korres; E Tsiridis; E Tsapakis
Journal:  Osteoporos Int       Date:  2012-08-09       Impact factor: 4.507

8.  Effects of IGF-II on promoting proliferation and regulating nitric oxide synthase gene expression in mouse osteoblast-like cell.

Authors:  Wei-lian Sun; Li-li Chen; Jie Yan; Zhong-sheng Yu
Journal:  J Zhejiang Univ Sci B       Date:  2005-07       Impact factor: 3.066

9.  Bone homeostasis in growth hormone receptor-null mice is restored by IGF-I but independent of Stat5.

Authors:  N A Sims; P Clément-Lacroix; F Da Ponte; Y Bouali; N Binart; R Moriggl; V Goffin; K Coschigano; M Gaillard-Kelly; J Kopchick; R Baron; P A Kelly
Journal:  J Clin Invest       Date:  2000-11       Impact factor: 14.808

10.  Cancellous bone properties and matrix content of TGF-beta2 and IGF-I in human tibia: a pilot study.

Authors:  Yener N Yeni; X Neil Dong; Bingbing Zhang; Gary J Gibson; David P Fyhrie
Journal:  Clin Orthop Relat Res       Date:  2009-05-27       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.